| 2026-08-31 |
There Was No Beating Moderna in August. These Are the Best and Worst S&P 500 Stocks for the Month. - barrons.com |
Google News |
| 2026-08-31 |
Moderna Stock (MRNA) Was the Best Performer in August - TipRanks |
Google News |
| 2026-08-30 |
Is It Too Late to Buy Moderna Stock After Its 127% Surge? - Yahoo Finance |
Google News |
| 2026-08-30 |
Is It Too Late to Buy Moderna Stock After Its 127% Surge? - The Motley Fool |
Google News |
| 2026-08-30 |
Tempus AI Stock (TEM) Opinions on Moderna Merck Cancer Vaccine News - Quiver Quantitative |
Google News |
| 2026-08-28 |
Moderna (MRNA) & Merck (MRK): What’s Happening With These Two Stocks? - Yahoo Finance |
Google News |
| 2026-08-28 |
Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes - Investing News Network |
Google News |
| 2026-08-28 |
This Moderna Analyst Turns Bullish; Here Are Top 3 Upgrades For Friday - Benzinga |
Google News |
| 2026-08-28 |
BioNTech Stock Falls on Cancer Vaccine Setback Days After Moderna’s Big Win - Barron's |
Google News |
| 2026-08-28 |
Q2 Earnings Highlights: Moderna (NASDAQ:MRNA) Vs The Rest Of The Therapeutics Stocks - Yahoo Finance |
Google News |
| 2026-08-27 |
Moderna to Offer $2 Billion in Convertibles to Boost Cancer Work - Bloomberg.com |
Google News |
| 2026-08-27 |
Moderna Stock (MRNA) Slides 3% on Plans for a $2B Private Placement - TipRanks |
Google News |
| 2026-08-27 |
Moderna raises $2 billion in convertible notes for cancer vaccine - Yahoo Finance |
Google News |
| 2026-08-27 |
Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes - Yahoo Finance |
Google News |
| 2026-08-27 |
Moderna’s $2B Convertible-Note Deal To Focus On Oncology Growth, Debt Repayment – But Retail Calls It A ‘Bull Trap’ - Yahoo Finance |
Google News |
| 2026-08-27 |
Moderna plans $2B note sale with dilution hedge at least 150% above shares - Stock Titan |
Google News |
| 2026-08-26 |
Moderna Stock Carries A Market Value Its Revenue Does Not Support - Trefis |
Google News |
| 2026-08-26 |
Moderna Drops 7% Despite a Fresh Wolfe Research Upgrade, BioNTech Slips - 24/7 Wall St. |
Google News |
| 2026-08-26 |
Moderna (NASDAQ:MRNA) Stock Surges 14%: Why MRNA Is Exploding Higher Again - Stocks Down Under |
Google News |
| 2026-08-26 |
Moderna Stock Carries A Market Value Its Revenue Does Not Support - Yahoo Finance |
Google News |